Literature DB >> 23256564

Novel twin-arginine translocation pathway-dependent phenotypes of Bacillus subtilis unveiled by quantitative proteomics.

Vivianne J Goosens1, Andreas Otto, Corinna Glasner, Carmine C Monteferrante, René van der Ploeg, Michael Hecker, Dörte Becher, Jan Maarten van Dijl.   

Abstract

The twin-arginine translocation (Tat) pathway is known to translocate fully folded proteins across bacterial, archaeal, and organellar membranes. To date, the mechanisms involved in processing, proofreading, and quality control of Tat substrates have remained largely elusive. Bacillus subtilis is an industrially relevant Gram-positive model bacterium. The Tat pathway in B. subtilis differs from that of other well-studied organisms in that it is composed of two complexes operating in parallel. To obtain a better understanding of this pathway in B. subtilis and to identify Tat-associated proteins, the B. subtilis 'Tat proteome' was investigated by quantitative proteomics. Metabolically labeled proteins from cytoplasmic, membrane, and extracellular fractions were analyzed by LC-MS/MS. Changes in the amounts of identified peptides allowed for quantitative comparisons of their abundance in tat mutant strains. The observed differences were suggestive of indirect or direct protein-protein relationships. The rich data set generated was then approached in hypothesis-driving and hypothesis-driven manners. The hypothesis-driving approach led to the identification of a novel delayed biofilm phenotype of certain tat mutant strains, whereas the hypothesis-driven approach identified the membrane protein QcrA as a new Tat substrate of B. subtilis. Thus, our quantitative proteomics analyses have unveiled novel Tat pathway-dependent phenotypes in Bacillus.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23256564     DOI: 10.1021/pr300866f

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  8 in total

1.  Co-factor insertion and disulfide bond requirements for twin-arginine translocase-dependent export of the Bacillus subtilis Rieske protein QcrA.

Authors:  Vivianne J Goosens; Carmine G Monteferrante; Jan Maarten van Dijl
Journal:  J Biol Chem       Date:  2014-03-20       Impact factor: 5.157

2.  The canonical twin-arginine translocase components are not required for secretion of folded green fluorescent protein from the ancestral strain of Bacillus subtilis.

Authors:  Anthony J Snyder; Sampriti Mukherjee; J Kyle Glass; Daniel B Kearns; Suchetana Mukhopadhyay
Journal:  Appl Environ Microbiol       Date:  2014-03-14       Impact factor: 4.792

Review 3.  Exploitation of Bacillus subtilis as a robust workhorse for production of heterologous proteins and beyond.

Authors:  Wenjing Cui; Laichuang Han; Feiya Suo; Zhongmei Liu; Li Zhou; Zhemin Zhou
Journal:  World J Microbiol Biotechnol       Date:  2018-09-10       Impact factor: 3.312

4.  A TatABC-type Tat translocase is required for unimpaired aerobic growth of Corynebacterium glutamicum ATCC13032.

Authors:  Dan Oertel; Sabrina Schmitz; Roland Freudl
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240

Review 5.  Transport of Folded Proteins by the Tat System.

Authors:  Kelly M Frain; Colin Robinson; Jan Maarten van Dijl
Journal:  Protein J       Date:  2019-08       Impact factor: 2.371

Review 6.  The ins and outs of Bacillus proteases: activities, functions and commercial significance.

Authors:  Colin R Harwood; Yoshimi Kikuchi
Journal:  FEMS Microbiol Rev       Date:  2022-01-18       Impact factor: 16.408

7.  Bacillus subtilis: from soil bacterium to super-secreting cell factory.

Authors:  Jan Maarten van Dijl; Michael Hecker
Journal:  Microb Cell Fact       Date:  2013-01-14       Impact factor: 5.328

8.  Diversity and evolution of bacterial twin arginine translocase protein, TatC, reveals a protein secretion system that is evolving to fit its environmental niche.

Authors:  Domenico Simone; Denice C Bay; Thorin Leach; Raymond J Turner
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.